Unresectable pancreatic adenocarcinoma with complete clinical response following chemoradiotherapy.
Locally advanced or metastatic disease is present in 2/3s of patients with pancreatic cancer. Pancreatic cancer patients are assessed as resectable, potentially resectable (borderline) and unresectable according to pre-operative examinations. The chance for operability may be enhanced by using adjuvant-neoadjuvant systemic chemotherapy, radiotherapy or both. The rates of R0 resection may be increased by means of treatment delivered this way. This case report presents a pancreatic adenocarcinoma case that was assessed to be resectable but was identified to be unresectable during surgical exploration, thus received adjuvant chemoradiotherapy. The patient was then re-evaluated, identified as resectable and received pancreaticoduodenectomy.
Clinic of Gastroenterology Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey.
Erol
E
Aksoy
Clinic of Gastroenterology Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey.
Murat
M
Ulaş
Clinic of Gastroenterology Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey.
Muhammet Kadri
MK
Çolakoğlu
Clinic of Gastroenterology Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey.
İlter
İ
Özer
Clinic of Gastroenterology Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey.
Erdal Birol
EB
Bostancı
Clinic of Gastroenterology Surgery, Türkiye Yüksek İhtisas Training and Research Hospital, Ankara, Turkey.
Musa
M
Akoğlu
Pancreas; adenocarcinoma; chemotherapy; resectability